
### [MONDO:0018959](http://purl.obolibrary.org/obo/MONDO_0018959)
**Label:** potassium-aggravated myotonia

**Subclasses:** [MONDO:0013234](http://purl.obolibrary.org/obo/MONDO_0013234) (hypokalemic periodic paralysis, type 2), [MONDO:0020481](http://purl.obolibrary.org/obo/MONDO_0020481) (myotonia fluctuans), [MONDO:0020482](http://purl.obolibrary.org/obo/MONDO_0020482) (myotonia permanens), [MONDO:0020483](http://purl.obolibrary.org/obo/MONDO_0020483) (Acetazolamide-responsive myotonia), [MONDO:0008223](http://purl.obolibrary.org/obo/MONDO_0008223) (hypokalemic periodic paralysis), [MONDO:0008224](http://purl.obolibrary.org/obo/MONDO_0008224) (hyperkalemic periodic paralysis), [MONDO:0012026](http://purl.obolibrary.org/obo/MONDO_0012026) (myotonia, potassium-aggravated), 

**Corr. equiv. classes:** [Orphanet:682](http://www.orpha.net/ORDO/Orphanet_682), [OMIM:608390](http://purl.obolibrary.org/obo/OMIM_608390), [OMIM:613345](http://purl.obolibrary.org/obo/OMIM_613345), [Orphanet:681](http://www.orpha.net/ORDO/Orphanet_681), [Orphanet:99734](http://www.orpha.net/ORDO/Orphanet_99734), [Orphanet:99735](http://www.orpha.net/ORDO/Orphanet_99735), [Orphanet:99736](http://www.orpha.net/ORDO/Orphanet_99736), [OMIM:170400](http://purl.obolibrary.org/obo/OMIM_170400), [OMIM:170500](http://purl.obolibrary.org/obo/OMIM_170500), 

**Class expressions from DL-Learner:**

- [HP:0003752](http://purl.obolibrary.org/obo/HP_0003752) (Episodic flaccid weakness) 73.42%
- [HP:0003752](http://purl.obolibrary.org/obo/HP_0003752) (Episodic flaccid weakness) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 73.42%
- [HP:0003752](http://purl.obolibrary.org/obo/HP_0003752) (Episodic flaccid weakness) and [HP:0011442](http://purl.obolibrary.org/obo/HP_0011442) (Abnormality of central motor function) 73.42%
- [HP:0003752](http://purl.obolibrary.org/obo/HP_0003752) (Episodic flaccid weakness) and [HP:0003768](http://purl.obolibrary.org/obo/HP_0003768) (Periodic paralysis) 73.42%
- [HP:0003470](http://purl.obolibrary.org/obo/HP_0003470) (Paralysis) and [HP:0003752](http://purl.obolibrary.org/obo/HP_0003752) (Episodic flaccid weakness) 73.42%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) and [HP:0003752](http://purl.obolibrary.org/obo/HP_0003752) (Episodic flaccid weakness) 73.42%
- [HP:0003752](http://purl.obolibrary.org/obo/HP_0003752) (Episodic flaccid weakness) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) 66.94%
- [HP:0003752](http://purl.obolibrary.org/obo/HP_0003752) (Episodic flaccid weakness) and [HP:0011042](http://purl.obolibrary.org/obo/HP_0011042) (Abnormality of potassium homeostasis) 66.94%
- [HP:0003752](http://purl.obolibrary.org/obo/HP_0003752) (Episodic flaccid weakness) and [HP:0010930](http://purl.obolibrary.org/obo/HP_0010930) (Abnormality of monovalent inorganic cation homeostasis) 66.94%
- [HP:0003752](http://purl.obolibrary.org/obo/HP_0003752) (Episodic flaccid weakness) and [HP:0010929](http://purl.obolibrary.org/obo/HP_0010929) (Abnormality of cation homeostasis) 66.94%
- [HP:0003111](http://purl.obolibrary.org/obo/HP_0003111) (Abnormality of ion homeostasis) and [HP:0003752](http://purl.obolibrary.org/obo/HP_0003752) (Episodic flaccid weakness) 66.94%
- [HP:0002900](http://purl.obolibrary.org/obo/HP_0002900) (Hypokalemia) and [HP:0003752](http://purl.obolibrary.org/obo/HP_0003752) (Episodic flaccid weakness) 66.94%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0003752](http://purl.obolibrary.org/obo/HP_0003752) (Episodic flaccid weakness) 66.94%
- [HP:0003752](http://purl.obolibrary.org/obo/HP_0003752) (Episodic flaccid weakness) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 66.94%
- [HP:0003752](http://purl.obolibrary.org/obo/HP_0003752) (Episodic flaccid weakness) and [HP:0011442](http://purl.obolibrary.org/obo/HP_0011442) (Abnormality of central motor function) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) 66.94%


